Thrombosis Flashcards
Unfractionated heparin
Class: Indirect thrombin inhibitors
MOA: Bind antithrombin, potentiating formation of antithrombin-coagulation factor complex (Xa, IIa)
Uses: Prevention and treatment of venous thromboembolism
SE: HIT, osteoporosis (long-term); Bleeding
Misc: Given parenterally; monitored via PTT (want 2-2.5X normal value); reversed by protamine
Dalteparin (Fragmin)
Class: Indirect thrombin inhibitors
MOA: LMWH that inhibits thrombin less effectively than Xa
Uses: Prevent thrombosis and embolism from clots
SE: Bleeding
Misc: Monitored by heparin assay (anti-factor Xa); longer half-life than heparin (1-2/day); reversed by protamine
Enoxaparin (Lovenox)
Class: Indirect thrombin inhibitors
MOA: LMWH that inhibits thrombin less effectively than Xa
Uses: Drug of choice in pregnancy; prevention and treatment of venous thromboembolism
SE: HIT; osteoporosis and thrombocytopenia uncommon; Bleeding
Misc: Can be monitored by heparin assay (anti-factor Xa); longer half-life than heparin (1-2/day); reversed by protamine
Tinzaparin (Innohep)
Class: Indirect thrombin inhibitors
MOA: LMWH that inhibits thrombin less effectively than Xa
SE: HIT; osteoporosis and thrombocytopenia uncommon; Bleeding
Misc: Monitored by heparin assay (anti-factor Xa); longer half-life than heparin (1-2/day); reversed by protamine
Fondaparinux (Arixtra)
Class: Indirect thrombin inhibitors MOA: Synthetic polysaccharide that binds active site of antithrombin; inhibits Xa Uses: Given for HIT patients SE: Bleeding Misc: No antidote
Warfarin (Coumadin)
Class: Vitamin K antagonist
MOA: Blocks vitamin K-dependent gamma-carboxylation of factors II, VII, IX, X, Protein C and S
Uses: Long-term anticoagulation
SE: Thrombosis (Protein C depression); Bleeding
Misc: Metabolism enhanced by drugs that induce P450 activity (e.g., barbiturates); monitored by PT/INR; reversed by vitamin K and factor concentrates or fresh frozen plasma; contraindicated in pregnancy (teratogen)
Lepirudin (Refludan)
Class: Direct thrombin inhibitor
MOA: Inactivate fibrinogen-bound AND unbound thrombin; irreversible
Misc: Administered parenterally; monitored by PTT; no antidote
Bivalirudin (Angiomax)
Class: Direct thrombin inhibitor
MOA: Inactivate fibrinogen-bound AND unbound thrombin; irreversible
Misc: Administered parenterally; monitored by PTT; no antidote
Argatroban (Acova)
Class: Direct thrombin inhibitor
MOA: Inactivate fibrinogen-bound AND unbound thrombin; irreversible
Misc: Administered parenterally; monitored by PTT; no antidote
Dabigatran (Pradaxa)
Class: Direct thrombin inhibitor
MOA: Inactivate fibrinogen-bound AND unbound thrombin; competitive (reversible)
Misc: Oral; no antidote
Rivaroxaban (Xarelto)
Class: Direct Xa inhibitor
MOA: Reversible bind active site of Xa
Misc: Oral; no antidote
Apixaban (Eliquis)
Class: Direct Xa inhibitor
MOA: Reversible bind active site of Xa
Misc: Oral; no antidote
Streptokinase (Streptase)
Class: Fibrinolytic
MOA: Lyse already formed clots by activating circulating plasminogen (not clot specific)
Uses: Acute MI, acute stroke, central DVT, multiple PE
Urokinase (Kinlytic)
Class: Fibrinolytic
MOA: Lyse already formed clots by activating circulating plasminogen
Uses: Acute MI, acute stroke, central DVT, multiple PE
Reteplase (Retavase)
Class: Fibrinolytic
MOA: Lyse already formed clots; more clot specific, less systemic activation
Uses: Acute MI, acute stroke, central DVT, multiple PE